J And J Consumer Inc patents expiration
1. Children's Motrin Cold patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6211246 | J AND J CONSUMER INC | Rapidly absorbed liquid compositions |
Jun, 2019
(4 years ago) | |
Drugs and Companies using IBUPROFEN; PSEUDOEPHEDRINE HYDROCHLORIDE ingredient
Market Authorisation Date: 01 August, 2000
Treatment: NA
Dosage: SUSPENSION;ORAL
CHILDREN'S MOTRIN COLD family patents
2. Children's Zyrtec Allergy patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6455533 | J AND J CONSUMER INC | Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
Jul, 2018
(5 years ago) | |
Drugs and Companies using CETIRIZINE HYDROCHLORIDE ingredient
Market Authorisation Date: 30 November, 2020
Treatment: Treatment of seasonal and perennial allergic rhinitis symptoms
Dosage: TABLET, CHEWABLE;ORAL
CHILDREN'S ZYRTEC ALLERGY family patents
3. Children's Zyrtec Hives Relief patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6455533 | J AND J CONSUMER INC | Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
Jul, 2018
(5 years ago) | |
Drugs and Companies using CETIRIZINE HYDROCHLORIDE ingredient
Market Authorisation Date: 30 November, 2020
Treatment: Treatment of seasonal and perennial allergic rhinitis symptoms
Dosage: TABLET, CHEWABLE;ORAL
CHILDREN'S ZYRTEC HIVES RELIEF family patents
4. Imodium A-d Ez Chews patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5489436 | J AND J CONSUMER INC | Taste mask coatings for preparation of chewable pharmaceutical tablets |
Feb, 2013
(11 years ago) | |
| US6814978 | J AND J CONSUMER INC | Process for preparing a soft tablet |
Aug, 2021
(2 years ago) | |
Drugs and Companies using LOPERAMIDE HYDROCHLORIDE ingredient
Market Authorisation Date: 24 July, 1997
Treatment: NA
Dosage: TABLET, CHEWABLE;ORAL
IMODIUM A-D EZ CHEWS family patents
5. Imodium Multi-symptom Relief patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5489436 | J AND J CONSUMER INC | Taste mask coatings for preparation of chewable pharmaceutical tablets |
Feb, 2013
(11 years ago) | |
| US5679376 | J AND J CONSUMER INC | Simethicone containing pharmaceutical compositions |
Oct, 2014
(9 years ago) | |
| US6103260 | J AND J CONSUMER INC | Simethicone/anhydrous calcium phosphate compositions |
Jul, 2017
(6 years ago) | |
Drugs and Companies using LOPERAMIDE HYDROCHLORIDE; SIMETHICONE ingredient
Market Authorisation Date: 26 June, 1996
Treatment: NA
Dosage: TABLET;ORAL
IMODIUM MULTI-SYMPTOM RELIEF family patents
6. Pepcid Ac patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5667794 | J AND J CONSUMER INC | Heartburn treatment |
May, 2015
(8 years ago) | |
|
US5667794 (Pediatric) | J AND J CONSUMER INC | Heartburn treatment |
Nov, 2015
(8 years ago) | |
| US5854267 | J AND J CONSUMER INC | Method for preventing heartburn |
Dec, 2015
(8 years ago) | |
|
US5854267 (Pediatric) | J AND J CONSUMER INC | Method for preventing heartburn |
Jun, 2016
(7 years ago) | |
| US6814978 | J AND J CONSUMER INC | Process for preparing a soft tablet |
Aug, 2021
(2 years ago) | |
|
US6814978 (Pediatric) | J AND J CONSUMER INC | Process for preparing a soft tablet |
Feb, 2022
(2 years ago) | |
Drugs and Companies using FAMOTIDINE ingredient
Market Authorisation Date: 24 September, 1998
Treatment: Heartburn
Dosage: TABLET, CHEWABLE;ORAL; TABLET;ORAL
PEPCID AC family patents
7. Pepcid Complete patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
|
US5229137 (Pediatric) | J AND J CONSUMER INC | Methods and pharmaceutical compositions for treating episodic heartburn |
Nov, 2012
(11 years ago) | |
| US5989588 | J AND J CONSUMER INC | Methods and compositions for preventing and treating heartburn |
Sep, 2017
(6 years ago) | |
|
US5989588 (Pediatric) | J AND J CONSUMER INC | Methods and compositions for preventing and treating heartburn |
Mar, 2018
(6 years ago) | |
| US6814978 | J AND J CONSUMER INC | Process for preparing a soft tablet |
Aug, 2021
(2 years ago) | |
|
US6814978 (Pediatric) | J AND J CONSUMER INC | Process for preparing a soft tablet |
Feb, 2022
(2 years ago) | |
Drugs and Companies using CALCIUM CARBONATE; FAMOTIDINE; MAGNESIUM HYDROXIDE ingredient
Market Authorisation Date: 16 October, 2000
Treatment: Method of use which is subject of the application
Dosage: TABLET, CHEWABLE;ORAL
PEPCID COMPLETE family patents
8. Zyrtec-d 12 Hour patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6489329 | J AND J CONSUMER INC | Pharmaceutical compositions for the treatment of rhinitis |
Apr, 2016
(8 years ago) | |
| US6469009 | J AND J CONSUMER INC | Pharmaceutical compositions for the treatment of rhinitis |
Jul, 2019
(4 years ago) | |
| US7014867 | J AND J CONSUMER INC | Tablet comprising cetirizine and pseudoephedrine |
Jun, 2022
(1 year, 10 months ago) | |
| US7226614 | J AND J CONSUMER INC | Tablet comprising cetirizine and pseudoephedrine |
Jun, 2022
(1 year, 10 months ago) | |
Drugs and Companies using CETIRIZINE HYDROCHLORIDE; PSEUDOEPHEDRINE HYDROCHLORIDE ingredient
Market Authorisation Date: 09 November, 2007
Treatment: Treatment of seasonal and perennial allergic rhinitis symptoms
Dosage: TABLET, EXTENDED RELEASE;ORAL
ZYRTEC-D 12 HOUR family patents